SHASQI, INC.
Targeting cancer with click chemistry
SAN FRANCISCO, United States · Founded 2021 · $51.9M raised
- Headquarters
- SAN FRANCISCO, California
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2G
- Total Funding
- $51.9M
- Last Round
- $1.9M GrantNov 2021
- Rounds
- 3
About
Shasqi is a clinical-stage biotech company using click chemistry — the 2022 Nobel Prize-winning technology — to develop targeted cancer therapeutics. Their proprietary CAPAC® platform delivers cancer drugs directly to tumors while minimizing toxicity to healthy tissue. Shasqi is the first company to apply click chemistry in human patients.
Summary
SHASQI, INC. is a Biotech company based in SAN FRANCISCO, United States, founded in 2021. It has raised $51.9M in total across 3 rounds, most recently a $1.9M Grant round in Nov 2021. Investors include National Cancer Institute, Thornapple River Capital and Juan Jaen.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Nov 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...